Treatment effects of fampridine on ambulation and upper extremity function in patients with multiple sclerosis from a real-world evidence cohort

被引：0
|
作者：
Kaya, L. [1 ]
van Munster, C. E. P. [1 ]
Lam, K. -H. [1 ]
Kalkers, N. F. [1 ]
Killestein, J. [1 ]
Uitdehaag, B. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam Neurosci, VUmc MS Ctr Amsterdam, Dept Neurol, Amsterdam, Netherlands
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1261
引用
收藏
页码：720 / 721
页数：2
相关论文
共 50 条
  • [21] Treatment decisions in multiple sclerosis — insights from real-world observational studies
    Maria Trojano
    Mar Tintore
    Xavier Montalban
    Jan Hillert
    Tomas Kalincik
    Pietro Iaffaldano
    Tim Spelman
    Maria Pia Sormani
    Helmut Butzkueven
    Nature Reviews Neurology, 2017, 13 : 105 - 118
  • [22] Upper extremity function and its relation with hand sensation and upper extremity strength in patients with multiple sclerosis
    Guclu-Gunduz, Arzu
    Citaker, Seyit
    Nazliel, Bijen
    Irkec, Ceyla
    NEUROREHABILITATION, 2012, 30 (04) : 369 - 374
  • [23] Real-World Use of Wearable Devices in a Large Multiple Sclerosis Cohort
    Foschini, Luca
    Medin, Jennie
    Bezlyak, Vladimir
    Stuck, David
    Silva, Diego
    Lee, Wei-Nchih
    NEUROLOGY, 2018, 90
  • [24] A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis
    Herman, Jorge Acevedo
    Khalighinejad, Farnaz
    York, Katherine
    Radu, Irina
    Morales, Idanis Berrios
    Ionete, Carolina
    Hemond, Christopher C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [25] Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: results from ms paths
    Hersh, C.
    Kieseier, B.
    De Moor, C.
    Miller, D.
    Campagnolo, D.
    Williams, J.
    Fitzgerald, K.
    Xiong, K.
    Mcginley, M.
    Hyland, M.
    Rudick, R.
    Ziemssen, T.
    Koulinska, I.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 609 - 609
  • [26] Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS
    Hersh, Carrie M.
    Kieseier, Bernd
    de Moor, Carl
    Miller, Deborah M.
    Campagnolo, Denise
    Williams, James R.
    Fitzgerald, Kathryn C.
    Xiong, Kuangnan
    McGinley, Marisa P.
    Hyland, Megan
    Rudick, Richard A.
    Ziemssen, Tjalf
    Koulinska, Irene
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)
  • [27] THE IMPACT OF TREATMENT ADHERENCE ON CLINICAL AND ECONOMIC OUTCOMES IN MULTIPLE SCLEROSIS: REAL-WORLD EVIDENCE FROM ALBERTA, CANADA
    Gerber, B.
    Cowling, T.
    Chen, G.
    Rivest, D.
    Yeung, M. M.
    Duquette, P.
    Kindundu, C.
    Barbeau, M.
    Haddad, P.
    VALUE IN HEALTH, 2016, 19 (07) : A437 - A437
  • [28] Characteristics of multiple sclerosis patients treated with highly effective DMTs in a large real-world cohort
    Hersh, C.
    Honomichl, R.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 858 - 858
  • [29] Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis - real-world evidence from Germany
    Papukchieva, Steffeni
    Stratil, Ann-Sophie
    Kahn, Maria
    Ness, Nils-Henning
    Hollnagel-Schmitz, Maike
    Gerencser, Vivien
    Rustemeier, Julia
    Eberl, Markus
    Friedrich, Benjamin
    Ziemssen, Tjalf
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
  • [30] Two-year real-world experience with ocrelizumab in the treatment of patients with multiple sclerosis
    Vollmer, B.
    Ijadi, N.
    Declusin, A.
    Nair, K.
    Sillau, S.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 595 - 596
12345